Endocrinology Pediatrics Oncology  

Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors

Dr Luca Toschi

Dr Luca Toschi
Publication Date

Sep 2021

info Summary and next episodes download Downloadable resources

Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.

Dr Luca Toschi has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, BMS, Boehringer, Ingelheim, Lilly, MSD, Pfizer and Roche. 
Programme summary
  • clock Duration 5 MIN
  • clock Downloadable resources Yes
  • pdf Infographic
  • clock Language(s) flag
Watch the video now
Share this programme
x-twitter
Supporter Acknowledgement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
LUNG CONNECT

LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories, Boehringer Ingelheim, Eisai Pharma AG, Revolution Medicines, and AstraZeneca.

Meet the experts Independent IME approved

Other programmes of interest

conference-update Conference update

Episode

3

of 3

episode
Oncology 
How are new data shaping the landscape in HER2-mutant NSCLC?

Insights from WCLC 2026

Experts
Dr Joshua Sabari
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2026
LUNG CONNECT PRECISION ONCOLOGY CONNECT
Educational programme supported by an Independent Educational Grant from Bayer.
conference-update Conference update
Oncology Hemato-oncology 
Myelofibrosis: Navigating unmet needs and overcoming clinical challenges

Expert perspectives on clinical trial highlights from EHA 2026

Experts
Prof. Francesco Passamonti, Prof. Claire Harrison
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Sep 2026
COR2ED
Brought to you by COR2ED Medical Affairs in collaboration with Menarini Stemline. This programme is intended for HCPS outside the UK. MED---2600258
Explore all programmes